These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9797081)

  • 1. Severe acquired hemophilia A successfully treated with activated recombinant human factor VII.
    Papadaki HA; Xylouri I; Valatas W; Petinarakis J; Kontopoulou I; Eliopoulos GD
    Ann Hematol; 1998 Sep; 77(3):123-5. PubMed ID: 9797081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of acquired factor VIII deficiency in a child using activated factor VII concentrates: case report and review of the literature.
    Bruggers CS; Bleak S
    J Pediatr Hematol Oncol; 2003 Jul; 25(7):578-80. PubMed ID: 12847330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII therapy in acquired hemophilia of the elderly.
    Dragani A; Di Bartolomeo E; La Barba G; Cavoni A; Lanzillotta P; Guizzardi G; Davì G
    Aging Clin Exp Res; 2004 Dec; 16(6):487-9. PubMed ID: 15739602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental hemophilia A and prophylactic treatment with intravenous immunoglobulin and recombinant factor VIIa in the newborn period: a case report.
    Gunel Karaburun IE; Kayki G; Aytac SS; Celik HT; Gumruk F; Yigit S
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):151-154. PubMed ID: 33196507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia A caused by factor VIII inhibitors: report of a case.
    Hosoya Y; Matsumura M; Madoiwa S; Zuiki T; Matsumoto S; Nunomiya S; Lefor A; Sata N; Yasuda Y
    Surg Today; 2013 Jun; 43(6):670-4. PubMed ID: 22890583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired hemophilia as a cause of primary postpartum hemorrhage.
    Borna S; Hantoushzadeh S
    Arch Iran Med; 2007 Jan; 10(1):107-10. PubMed ID: 17198466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery.
    Doughty HA; Northeast A; Sklair L; Roques T; Young AE; Savidge GF; Hunt BJ
    Blood Coagul Fibrinolysis; 1995 Apr; 6(2):125-8. PubMed ID: 7605877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Refractory acquired hemophilia A successfully treated with CVP].
    Kaneko H; Okada N; Matsui Y; Nishizawa M; Watanabe M; Miura Y; Tsudo M
    Rinsho Ketsueki; 2009 Feb; 50(2):110-2. PubMed ID: 19265305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
    Conesa V; Mompel A; Lopez F; Marín F; Ruiz J; Navarro F; Gomez A
    Am J Hematol; 2002 Aug; 70(4):329-30. PubMed ID: 12210816
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acquired haemophilia A: a rare but life-threatening auto-immune disorder].
    Twiss E; Franschman G; Regelink J; Zuidema W
    Ned Tijdschr Geneeskd; 2010; 154():A1749. PubMed ID: 20619047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.
    Ducore J; Lawrence JB; Simpson M; Boggio L; Bellon A; Burggraaf J; Stevens J; Moerland M; Frieling J; Reijers J; Wang M
    Haemophilia; 2017 Nov; 23(6):844-851. PubMed ID: 28984010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired hemophilia complicated with hemorrhage induced acute renal failure].
    Takimoto M; Nagura S; Sano F; Nagoshi H; Miura I
    Rinsho Ketsueki; 2010 Jun; 51(6):407-12. PubMed ID: 20622487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia a patient with inhibitor.
    Morimoto Y; Yoshioka A; Shima M; Kirita T
    J Oral Maxillofac Surg; 2003 Sep; 61(9):1095-7. PubMed ID: 12966487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.